Citadel Advisors
ZOM

Citadel Advisors’s Zomedica Corp. ZOM Stock Holding History

Citadel Advisors’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-443,382
Closed -$64.8K – 15708
2024
Q2 		$64.8K Sell
443,382
-299,725
-40% -$44.9K ﹤0.01% 11469
2024
Q1 		$108K Sell
743,107
-73,490
-9% -$10.3K ﹤0.01% 11243
2023
Q4 		$163K Buy
+816,597
New +$143K ﹤0.01% 10253
2023
Q3 		– Sell
-73,889
Closed -$14.8K – 15650
2023
Q2 		$14.8K Buy
+73,889
New +$15K ﹤0.01% 12988
2022
Q4 		– Sell
-15,705
Closed -$3K – 16092
2022
Q3 		$3K Sell
15,705
-27,153
-63% -$7.18K ﹤0.01% 12424
2022
Q2 		$9K Sell
42,858
-1,788,212
-98% -$455K ﹤0.01% 12625
2022
Q1 		$617K Buy
1,831,070
+1,234,666
+207% +$404K ﹤0.01% 8889
2021
Q4 		$183K Sell
596,404
-84,967
-12% -$38.3K ﹤0.01% 11984
2021
Q3 		$357K Buy
+681,371
New +$402K ﹤0.01% 10680
2021
Q2 		– Sell
-2,020,871
Closed -$3.19M – 15009
2021
Q1 		$3.19M Buy
2,020,871
+1,283,339
+174% +$2.1M ﹤0.01% 5289
2020
Q4 		$170K Sell
737,532
-393,732
-35% -$50.2K ﹤0.01% 9860
2020
Q3 		$125K Buy
1,131,264
+595,252
+111% +$82K ﹤0.01% 9136
2020
Q2 		$128K Buy
536,012
+519,470
+3,140% +$99K ﹤0.01% 8853
2020
Q1 		$3K Sell
16,542
-49,108
-75% -$11.3K ﹤0.01% 9508
2019
Q4 		$22K Buy
65,650
+26,509
+68% +$8.92K ﹤0.01% 8930
2019
Q3 		$15K Buy
+39,141
New +$12.1K ﹤0.01% 9003
2019
Q2 		– Sell
-50,343
Closed -$18K – 10183
2019
Q1 		$18K Buy
50,343
+32,883
+188% +$29K ﹤0.01% 9083
2018
Q4 		$21K Sell
17,460
-15,950
-48% -$25.3K ﹤0.01% 8744
2018
Q3 		$62K Buy
+33,410
New +$71.5K ﹤0.01% 8754
2018
Q1 		– Sell
-26,090
Closed -$52K – 9025
2017
Q4 		$52K Buy
+26,090
New +$58K ﹤0.01% 7625

Other funds holding ZOM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Citadel Advisors's ZOM Position: Q3 2024 in Review

Citadel Advisors sold out of Zomedica Corp. (ZOM) in Q3 2024, closing a stake of 443,382 shares — an estimated $64.8K sold.

Citadel Advisors first reported a position in ZOM in Q4 2017 and held it in 20 quarters. The position peaked at $3.19M in Q1 2021. 84 funds tracked by Wall St. Rank hold ZOM as of Q3 2024.

  • Citadel Advisors reported no remaining Zomedica Corp. position as of Q3 2024 after selling out during the quarter.
  • Citadel Advisors sold 443,382 Zomedica Corp. shares in Q3 2024, an estimated $64.8K.
  • Citadel Advisors first reported a position in Zomedica Corp. in Q4 2017 and held it in 20 quarters.
  • Citadel Advisors's Zomedica Corp. position peaked at $3.19M in Q1 2021.
  • 84 funds tracked by Wall St. Rank held Zomedica Corp. as of Q3 2024.

Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.